Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patients with a justified indication for biopsy: *Those with a suspicious digital rectal exam( nodular, hard) *and/or those with an initial serum PSA level above 4 ng/ml - Patients whose life expectancy is greater than 10 years
Exclusion criteria
Exclusion criteria: -Patients with a history of prostate biopsy. - Patients with a bladder catheter. - Patients with a contraindication to ciprofloxacin (history of tendinopathy or hypersensitivity to a product of the quinolone family). - Patients with a contraindication to prostate biopsy (uncorrected coagulation abnormality, untreated urinary tract infection). - Patients with severe renal or hepatic insufficiency. - Patients with a life expectancy of less than 10 years. - Patients with missing data on the medical record
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the occurrence of infectious signs and prostatitis during the 15 days following the b prostate biopsy.;Occurrence of bleeding complication | — |
Secondary
| Measure | Time frame |
|---|---|
| prevalence of urinary and digestive carriage of germs resistant to fluoroquinilones | — |
Countries
Tunisia
Contacts
Urology Departement